🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this clinical trial is to learn how roginolisib works in compar...
Status
Active Not Recruiting
Location
SSD Tumori Rari e Melanoma Viale Orazio Flacco
Start Date
2025-02-27
Trial ID
NCT06717126
Treatments Being Tested
The goal of this clinical trial is to learn how roginolisib works in compar...
Status
Recruiting
Location
Azienda Ospedaliero Universitaria Careggi Firenze, Struttura Complessa di Ematologia
Start Date
2025-11-17
Trial ID
NCT06887803
Treatments Being Tested
This study is a platform trial for the evaluation of new drugs or combinati...
Status
Recruiting
Location
Institut d'Hématologie de Basse Normandie - Service Hématologie (CHU Hôpital Côte de Nacre)
Start Date
2025-08-20
Trial ID
NCT07018752
Treatments Being Tested
The goal of this clinical trial is to learn how roginolisib works in combin...
Status
Active Not Recruiting
Location
Antwerp University Hospital
Start Date
2025-04-22
Trial ID
NCT06879717
Treatments Being Tested
The purpose of Part 1 of this First-in-Human trial is to evaluate the safet...
Status
Completed
Location
Centro Ricerche Cliniche di Verona srl
Start Date
2021-06-28
Trial ID
NCT05027568
Treatments Being Tested
This research study will test the safety and anticancer activity of the com...
Status
Recruiting
Location
Dana-Farber Cancer Institute
Start Date
2025-03-19
Trial ID
NCT06644183
Treatments Being Tested
This is a combination study of Tebentafusp and the PI3Kdelta inhibitor, Rog...
Status
Recruiting
Location
St Vincents Hospital
Start Date
2026-02-01
Trial ID
NCT07203391
Treatments Being Tested